| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |